BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24046180)

  • 1. Myeloid/NK cell acute leukemia with unique blast morphology: de novo or secondary leukemia?
    Imashuku S; Kudo N; Sungkyu P; Shinbo M; Furukawa T; Iwae S
    Int J Hematol; 2013 Oct; 98(4):509-11. PubMed ID: 24046180
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute lymphoblastic leukemia with T + PH1 monocytosis: a case report].
    Braham Jmili N; Sendi H; Khelif A
    Ann Biol Clin (Paris); 2011; 69(4):473-5. PubMed ID: 21896415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid/NK cell acute leukemia.
    Chen B; Xu X; Ji M; Lin G
    Int J Hematol; 2009 Apr; 89(3):365-367. PubMed ID: 19326059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
    Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
    Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual childhood biphenotypic acute leukemia with a yet unreported t(3;13)(p25.1;q13).
    Marques-Salles Tde J; Barros JE; Soares-Ventura EM; Cartaxo Muniz MT; Santos N; Ferreira da Silva E; Silva ML; Liehr T; Mkrtchyan H
    Leuk Res; 2010 Aug; 34(8):e206-7. PubMed ID: 20338638
    [No Abstract]   [Full Text] [Related]  

  • 7. CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
    Naik J; Themeli M; de Jong-Korlaar R; Ruiter RWJ; Poddighe PJ; Yuan H; de Bruijn JD; Ossenkoppele GJ; Zweegman S; Smit L; Mutis T; Martens ACM; van de Donk NWCJ; Groen RWJ
    Haematologica; 2019 Mar; 104(3):e100-e103. PubMed ID: 30190344
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishment of cell line with NK/NKT phenotype from myeloid NK cell acute leukemia.
    Darji A; Desai N; Modi R; Khamar B; Rajkumar S
    Leuk Res; 2017 Oct; 61():77-83. PubMed ID: 28934678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD33 expression on natural killer cells is a potential confounder for residual disease detection in acute myeloid leukemia by flow cytometry.
    Eckel AM; Cherian S; Miller V; Soma L
    Cytometry B Clin Cytom; 2020 Mar; 98(2):174-178. PubMed ID: 31622025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blasts with abundant cytoplasmic granules: acute myeloid leukemia or granular acute lymphoblastic leukemia?
    Xu J; Li S
    Blood; 2017 Jan; 129(4):537. PubMed ID: 28126958
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
    Cheng J; Klairmont MM; Choi JK
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triphenotypic acute leukemia with TRAP-positive blasts: A pathological rarity.
    Sharma P; Asthana B; Tyagi S
    Leuk Res; 2009 Jul; 33(7):e83-4. PubMed ID: 19237193
    [No Abstract]   [Full Text] [Related]  

  • 13. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
    Sun T; Pashaei S; Jaffrey I; Ryder J
    Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auer rods aid in the diagnosis of mixed phenotype acute leukemia.
    Feng Y; Fu J
    Int J Hematol; 2021 Mar; 113(3):313-314. PubMed ID: 33398632
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of T-cell lymphoma in a patient with acute myelogenous leukemia.
    Thomas X; Anglaret B; Treille-Ritouet D; Bastion Y; Fiere D; Archimbaud E
    Ann Hematol; 1996 Aug; 73(2):95-8. PubMed ID: 8774619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
    Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
    Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
    Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
    Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
    Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
    Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P
    Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.